Products for Research Use Only

Tirapazamine

CAT: 0013-GTR19159783-01Size: 500 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19159783-01Size:500 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Trapazamine, also known as SR-4233, DNA-damaging drug potentially for the treatment of cervical carcinoma, head and neck cancer. Tirapazamine is activated to its toxic form preferentially in the hypoxic areas of solid tumors. Cells in these regions are resistant to killing by radiotherapy and most anticancer drugs. Thus the combination of tirapazamine with conventional anticancer treatments is particularly effective. (In Vitro) :Tirapazamine (SR259075) is the optimal drug for combination therapy using Pba. (In Vivo) :Tirapazamine (SR259075) (1mg; intravenously injected; twice at a 24-h interval) shows a synergetic effect to kill tumor cells because TPZ was activated under the hypoxic conditions that originated from the PDT with Pba and laser irradiation. .
CAS Number
27314-97-2
Product Name Alternative
Tirapazamine | Tirazone | SR 4233 | SR-4233 | WIN 59075
Purity
>98% (HPLC)
Solubility
DMSO : ≥ 39 mg/m; 218.92 mM
Smiles
Nc1nn (=O) c2ccccc2n1=O
Molecular Formula
C7H6N4O2
Molecular Weight
178.15
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
3-aminobenzo[e][1,2,4]triazine 1,4-dioxide